ストックスクリーナーアプリを入手
6.3707
2.24%
0.1307
前日終値:
$6.24
開ける：
$6.215
24時間の取引高:
77,895
Relative Volume:
0.03
時価総額：
$14.49M
収益：
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
+1.27%
1か月 パフォーマンス:
+12.72%
6か月 パフォーマンス:
+13.32%
1年 パフォーマンス:
+0.00%
1日の値動き範囲:
$6.01
$6.6145
1週間の範囲:
$5.91
$6.6145
52週間の値動き範囲:
$2.70
$18.00
Quantum Biopharma Ltd Stock (QNTM) Company Profile
QNTM を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
QNTM
Quantum Biopharma Ltd
|
6.3707 | 14.49M | 0 | 0 | 0 | 0.00 |
|
ZTS
Zoetis Inc
|
149.68 | 66.56B | 9.26B | 2.49B | 2.30B | 5.47 |
|
HLN
Haleon Plc Adr
|
10.45 | 45.61B | 14.35B | 1.85B | 0 | 0.4023 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.31 | 45.01B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
13.98 | 15.25B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
292.21 | 12.79B | 2.76B | 1.11B | 898.10M | 22.77 |
Quantum Biopharma Ltd (QNTM) 最新ニュース
Quantum BioPharma adds Kevin Malone as advisor - Investing.com
Quantum Biopharma Announces Advocate Against Naked Short - GlobeNewswire
Quantum Biopharma Announces Advocate Against Naked Short Selling and Stock Manipulation, Kevin - Bluefield Daily Telegraph
Quantum BioPharma Strengthens Defense: Short Selling Expert Kevin Malone to Combat Market Manipulation - Stock Titan
Quantum BioPharma Announces RSU Grant and Debt Settlement - TipRanks
Quantum BioPharma Corporate Update - Newsfile
1 ‘Defensive’ Cathie Wood Stock to Buy While It’s at a ‘Great Entry Point’ - The Globe and Mail
West Fraser Timber Ltd Stock Analysis: Q1 2025 Earnings and Future Outlook - The Globe and Mail
Meta Platforms (META) Can Withstand an Advertising Slowdown, Says Citigroup - The Globe and Mail
Stocks Pressured by Fears of a Tariff-Induced Slowdown - The Globe and Mail
Why ServiceNow Stock Is Gaining Today - The Globe and Mail
What to Know About Jeff Bezos’ Secret EV Startup Slate Auto - The Globe and Mail
Allied Announces April 2025 Distribution - The Globe and Mail
Rocket Lab Stock (RKLB) Soars on Major Hypersonic Tech Deals with US and UK Governments - The Globe and Mail
Abbott Laboratories (ABT) Q1 Earnings: What To Expect - The Globe and Mail
BWXT Moving Forward to Support National Security, Domestic Uranium Enrichment Mission - The Globe and Mail
Quantum Biopharma Wins Reconsideration Motion by Dr. Raza Bokhar - GuruFocus
Quantum BioPharma (QNTM) Prevails in Legal Dispute with Former C - GuruFocus
Lithium Argentina to Release First Quarter 2025 Results on May 14, 2025 - The Globe and Mail
Quantum BioPharma wins legal battle against former CEO By Investing.com - Investing.com South Africa
Market Analysis: April 14th, 2025 - The Globe and Mail
Top 3 Large Cap Stocks Insiders Bought in Q1: Buy, Sell, or Hold - The Globe and Mail
3 Hot New IPOs Defying the 2025 Market Slump - The Globe and Mail
Canadian Insurance Market Remains Strong Amidst Market Volatility: Aon Report - The Globe and Mail
1 of Wall Street’s Favorite Stock for Long-Term Investors and 2 to Ignore - The Globe and Mail
Quantum BioPharma Secures Legal Victory with $180,000 Award - TipRanks
Quantum BioPharma wins legal battle against former CEO - Investing.com
Quantum Biopharma Wins Reconsideration Motion by Dr. Raza Bokhari at the Court of Appeal for Ontario - GlobeNewswire
Latest: Court Upholds $2.8M Award in Quantum BioPharma's Favor Against Former CEO - Stock Titan
2 AI Stocks That Could Help Set You Up for Life - The Globe and Mail
3 ETFs to Save Your Portfolio Right Now - The Globe and Mail
Are These 3 Retail Stocks Oversold or Really in Trouble? - The Globe and Mail
Should You Buy ChargePoint While It's Below $0.70? - The Globe and Mail
BMO Announces Election of Board of Directors - The Globe and Mail
Stocks in play: Bonterra Energy Corp - The Globe and Mail
Time to Load Up on the New Look of SCHD - The Globe and Mail
1 Undervalued Growth Stock You Can Buy During the Stock Market Drop of 2025 - The Globe and Mail
3 Reasons to Avoid SWIM and 1 Stock to Buy Instead - The Globe and Mail
Quantum BioPharma Licensee Celly Nutrition Announces Landmark Pa - GuruFocus
Quantum BioPharma’s licensee expands retail reach with AATAC deal By Investing.com - Investing.com South Africa
Quantum BioPharma Licensee Celly Nutrition Partners With Asian American Trade Associations Council - marketscreener.com
Quantum BioPharma's licensee expands retail reach with AATAC deal By Investing.com - Investing.com India
Quantum BioPharma's licensee expands retail reach with AATAC deal - Investing.com
Quantum BioPharma Licensee Celly Nutrition Announces Landmark Partnership with the Asian American Trade Associations Council (AATAC) to Expand Retail Availability of its Alcohol Detox Beverage unbuzzd™ - GlobeNewswire
Quantum's Alcohol Detox Drink Lands Massive Deal: Coming to 80,000+ US Stores - Stock Titan
Cathie Wood Snaps Up $30M in Coinbase Stock (COIN) as Tariff Sell-Off Deepens - The Globe and Mail
Press Release Distribution & PR Platform - ACCESS Newswire
Taiwan Semi Stock’s (TSM) Selloff Is ‘Overdone,’ Says BofA - The Globe and Mail
Micro Cap AI Distributor Defies Market Weakness with Record Revenue and Rising Margins - The Globe and Mail
Levi's (LEVI) Reports Q1: Everything You Need To Know Ahead Of Earnings - The Globe and Mail
Lancaster Colony Stock (LANC) Defies Down Market on Record-Breaking Sales Performance - The Globe and Mail
Quantum Biopharma Ltd (QNTM) 財務データ
Quantum Biopharma Ltd (QNTM) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
1.71%
大文字化:
|
ボリューム (24 時間):